3D Printed Drugs
The global 3D Printed Drugs market was valued at 216.42 Million USD in 2021 and will grow with a CAGR of 3.88% from 2021 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. Spritam is the only 3D printed drug which has received FDA approval. This drug was first available in the market in 2016, and can be used to treat epilepsy.
By Market Verdors
Aprecia Pharmaceuticals
GlaxoSmithKline Plc
Hewlett Packard Caribe
BV
LLC
3D Printer Drug Machine
FabRx Ltd
By Types
Spritam
By Applications
Children
Elderly
Key Indicators Analysed
Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.
Opportunities and DriversIdentifying the Growing Demands and New Technology
Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by 3D Printed Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global 3D Printed Drugs Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Spritam
1.5 Market by Application
1.5.1 Global 3D Printed Drugs Market Share by Application: 2022-2027
1.5.2 Children
1.5.3 Elderly
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global 3D Printed Drugs Market
1.8.1 Global 3D Printed Drugs Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global 3D Printed Drugs Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global 3D Printed Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global 3D Printed Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers 3D Printed Drugs Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global 3D Printed Drugs Sales Volume Market Share by Region (2016-2021)
3.2 Global 3D Printed Drugs Sales Revenue Market Share by Region (2016-2021)
3.3 North America 3D Printed Drugs Sales Volume
3.3.1 North America 3D Printed Drugs Sales Volume Growth Rate (2016-2021)
3.3.2 North America 3D Printed Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia 3D Printed Drugs Sales Volume
3.4.1 East Asia 3D Printed Drugs Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia 3D Printed Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe 3D Printed Drugs Sales Volume (2016-2021)
3.5.1 Europe 3D Printed Drugs Sales Volume Growth Rate (2016-2021)
3.5.2 Europe 3D Printed Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia 3D Printed Drugs Sales Volume (2016-2021)
3.6.1 South Asia 3D Printed Drugs Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia 3D Printed Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia 3D Printed Drugs Sales Volume (2016-2021)
3.7.1 Southeast Asia 3D Printed Drugs Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia 3D Printed Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East 3D Printed Drugs Sales Volume (2016-2021)
3.8.1 Middle East 3D Printed Drugs Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East 3D Printed Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa 3D Printed Drugs Sales Volume (2016-2021)
3.9.1 Africa 3D Printed Drugs Sales Volume Growth Rate (2016-2021)
3.9.2 Africa 3D Printed Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania 3D Printed Drugs Sales Volume (2016-2021)
3.10.1 Oceania 3D Printed Drugs Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania 3D Printed Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America 3D Printed Drugs Sales Volume (2016-2021)
3.11.1 South America 3D Printed Drugs Sales Volume Growth Rate (2016-2021)
3.11.2 South America 3D Printed Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World 3D Printed Drugs Sales Volume (2016-2021)
3.12.1 Rest of the World 3D Printed Drugs Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World 3D Printed Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America 3D Printed Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia 3D Printed Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe 3D Printed Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia 3D Printed Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia 3D Printed Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East 3D Printed Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa 3D Printed Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania 3D Printed Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America 3D Printed Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World 3D Printed Drugs Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global 3D Printed Drugs Sales Volume Market Share by Type (2016-2021)
14.2 Global 3D Printed Drugs Sales Revenue Market Share by Type (2016-2021)
14.3 Global 3D Printed Drugs Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global 3D Printed Drugs Consumption Volume by Application (2016-2021)
15.2 Global 3D Printed Drugs Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in 3D Printed Drugs Business
16.1 Aprecia Pharmaceuticals
16.1.1 Aprecia Pharmaceuticals Company Profile
16.1.2 Aprecia Pharmaceuticals 3D Printed Drugs Product Specification
16.1.3 Aprecia Pharmaceuticals 3D Printed Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 GlaxoSmithKline Plc
16.2.1 GlaxoSmithKline Plc Company Profile
16.2.2 GlaxoSmithKline Plc 3D Printed Drugs Product Specification
16.2.3 GlaxoSmithKline Plc 3D Printed Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Hewlett Packard Caribe
16.3.1 Hewlett Packard Caribe Company Profile
16.3.2 Hewlett Packard Caribe 3D Printed Drugs Product Specification
16.3.3 Hewlett Packard Caribe 3D Printed Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 BV
16.4.1 BV Company Profile
16.4.2 BV 3D Printed Drugs Product Specification
16.4.3 BV 3D Printed Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 LLC
16.5.1 LLC Company Profile
16.5.2 LLC 3D Printed Drugs Product Specification
16.5.3 LLC 3D Printed Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 3D Printer Drug Machine
16.6.1 3D Printer Drug Machine Company Profile
16.6.2 3D Printer Drug Machine 3D Printed Drugs Product Specification
16.6.3 3D Printer Drug Machine 3D Printed Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 FabRx Ltd
16.7.1 FabRx Ltd Company Profile
16.7.2 FabRx Ltd 3D Printed Drugs Product Specification
16.7.3 FabRx Ltd 3D Printed Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 3D Printed Drugs Manufacturing Cost Analysis
17.1 3D Printed Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of 3D Printed Drugs
17.4 3D Printed Drugs Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 3D Printed Drugs Distributors List
18.3 3D Printed Drugs Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of 3D Printed Drugs (2022-2027)
20.2 Global Forecasted Revenue of 3D Printed Drugs (2022-2027)
20.3 Global Forecasted Price of 3D Printed Drugs (2016-2027)
20.4 Global Forecasted Production of 3D Printed Drugs by Region (2022-2027)
20.4.1 North America 3D Printed Drugs Production, Revenue Forecast (2022-2027)
20.4.2 East Asia 3D Printed Drugs Production, Revenue Forecast (2022-2027)
20.4.3 Europe 3D Printed Drugs Production, Revenue Forecast (2022-2027)
20.4.4 South Asia 3D Printed Drugs Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia 3D Printed Drugs Production, Revenue Forecast (2022-2027)
20.4.6 Middle East 3D Printed Drugs Production, Revenue Forecast (2022-2027)
20.4.7 Africa 3D Printed Drugs Production, Revenue Forecast (2022-2027)
20.4.8 Oceania 3D Printed Drugs Production, Revenue Forecast (2022-2027)
20.4.9 South America 3D Printed Drugs Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World 3D Printed Drugs Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of 3D Printed Drugs by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of 3D Printed Drugs by Country
21.2 East Asia Market Forecasted Consumption of 3D Printed Drugs by Country
21.3 Europe Market Forecasted Consumption of 3D Printed Drugs by Countriy
21.4 South Asia Forecasted Consumption of 3D Printed Drugs by Country
21.5 Southeast Asia Forecasted Consumption of 3D Printed Drugs by Country
21.6 Middle East Forecasted Consumption of 3D Printed Drugs by Country
21.7 Africa Forecasted Consumption of 3D Printed Drugs by Country
21.8 Oceania Forecasted Consumption of 3D Printed Drugs by Country
21.9 South America Forecasted Consumption of 3D Printed Drugs by Country
21.10 Rest of the world Forecasted Consumption of 3D Printed Drugs by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices